SEROTONIN-NOREPINEPHRINE INTERACTIONS IN THE TREMOROLYTIC ACTIONS OF PHENOXYBENZAMINE AND TRAZODONE

被引：0
|
作者：
HWANG, EC [1 ]
VANWOERT, MH [1 ]
机构：
[1] CUNY,MT SINAI SCH MED,DEPT PHARMACOL,NEW YORK,NY 10029
来源：
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 1979年 / 10卷 / 01期
关键词：
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：27 / 29
页数：3
相关论文
共 50 条
  • [41] Serotonin-Norepinephrine Reuptake Inhibitor-Associated Mixed Episode in an Adolescent With Schizoaffective Disorder
    Chang, Jane Pei-Chen
    Chi, Mei-Hung
    Chiu, Yen-Nan
    Tsai, Wen-Che
    Gau, Susan Shur-Fen
    Shang, Chi-Yung
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (04) : 525 - 526
  • [42] Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine
    Joffe, Hadine
    Soares, Claudio N.
    Petrillo, Laura F.
    Viguera, Adele C.
    Somley, Brittny L.
    Koch, Jennifer K.
    Cohen, Lee S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) : 943 - 950
  • [43] Safety of Oxymorphone Extended Release in Depressed Patients Taking Selective Serotonin- or Serotonin-Norepinephrine Reuptake Inhibitors
    Peniston, John H.
    Potts, Susan
    Hu, Xiaojun
    Wieman, Matthew S.
    AMERICAN JOURNAL ON ADDICTIONS, 2012, 21 (04): : 394 - 394
  • [44] Tolerability of Concomitant Use of Selective Serotonin Reuptake Inhibitors or Serotonin-Norepinephrine Reuptake Inhibitors and Oxymorphone Extended Release
    Peniston, John H.
    Hu, Xiaojun
    Potts, Susan L.
    Wieman, Matthew S.
    Turk, Dennis C.
    POSTGRADUATE MEDICINE, 2012, 124 (02) : 114 - 122
  • [45] Treatment of Alzheimer's Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions
    Ashford, John Wesson
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (03) : 923 - 930
  • [46] Desvenlafaxine: A New Serotonin-Norepinephrine Reuptake Inhibitor for the Treatment of Adults With Major Depressive Disorder
    Perry, Richard
    Cassagnol, Manouchkathe
    CLINICAL THERAPEUTICS, 2009, 31 : 1374 - 1404
  • [47] Delayed Presentation of Posterior Reversible Encephalopathy Syndrome in the Setting of Serotonin-Norepinephrine Reuptake Inhibitors
    Bhutada, Abhishek S.
    Kodankandath, Thomas V.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [48] Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats
    Umehara, Masato
    Ago, Yukio
    Fujita, Kazumi
    Hiramatsu, Naoki
    Takuma, Kazuhiro
    Matsuda, Toshio
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 702 (1-3) : 250 - 257
  • [49] Report of Bilateral Acute Angle-closure Crisis Induced by Serotonin-norepinephrine Reuptake Inhibitors
    Yoon, Jihyun
    Jun, Roo Min
    Choi, Kyu Ryong
    Han, Kyung Eun
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (12): : 1356 - 1362
  • [50] TREATMENT WITH TRAZODONE PLUS PHENOXYBENZAMINE ACCELERATES DEVELOPMENT OF DECREASED TYPE-2 SEROTONIN BINDING IN RAT CORTEX
    TAYLOR, DP
    ALLEN, LE
    ASHWORTH, EM
    BECKER, JA
    HYSLOP, DK
    RIBLET, LA
    NEUROPHARMACOLOGY, 1981, 20 (05) : 513 - 516
12345